Medical Care
Global Allergy Immunotherapies Market Research Report 2025
- Mar 11, 25
- ID: 27552
- Pages: 62
- Figures: 67
- Views: 18
The global market for Allergy Immunotherapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.
The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALK
Stallergenes
HAL
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergy Immunotherapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.
The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALK
Stallergenes
HAL
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergy Immunotherapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Allergy Immunotherapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergy Immunotherapies Market Perspective (2020-2031)
2.2 Global Allergy Immunotherapies Growth Trends by Region
2.2.1 Global Allergy Immunotherapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Allergy Immunotherapies Historic Market Size by Region (2020-2025)
2.2.3 Allergy Immunotherapies Forecasted Market Size by Region (2026-2031)
2.3 Allergy Immunotherapies Market Dynamics
2.3.1 Allergy Immunotherapies Industry Trends
2.3.2 Allergy Immunotherapies Market Drivers
2.3.3 Allergy Immunotherapies Market Challenges
2.3.4 Allergy Immunotherapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergy Immunotherapies Players by Revenue
3.1.1 Global Top Allergy Immunotherapies Players by Revenue (2020-2025)
3.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2020-2025)
3.2 Global Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Allergy Immunotherapies Revenue
3.4 Global Allergy Immunotherapies Market Concentration Ratio
3.4.1 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergy Immunotherapies Revenue in 2024
3.5 Global Key Players of Allergy Immunotherapies Head office and Area Served
3.6 Global Key Players of Allergy Immunotherapies, Product and Application
3.7 Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergy Immunotherapies Breakdown Data by Type
4.1 Global Allergy Immunotherapies Historic Market Size by Type (2020-2025)
4.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031)
5 Allergy Immunotherapies Breakdown Data by Application
5.1 Global Allergy Immunotherapies Historic Market Size by Application (2020-2025)
5.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Allergy Immunotherapies Market Size (2020-2031)
6.2 North America Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Allergy Immunotherapies Market Size by Country (2020-2025)
6.4 North America Allergy Immunotherapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergy Immunotherapies Market Size (2020-2031)
7.2 Europe Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Allergy Immunotherapies Market Size by Country (2020-2025)
7.4 Europe Allergy Immunotherapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergy Immunotherapies Market Size (2020-2031)
8.2 Asia-Pacific Allergy Immunotherapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Allergy Immunotherapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Allergy Immunotherapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergy Immunotherapies Market Size (2020-2031)
9.2 Latin America Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Allergy Immunotherapies Market Size by Country (2020-2025)
9.4 Latin America Allergy Immunotherapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergy Immunotherapies Market Size (2020-2031)
10.2 Middle East & Africa Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Allergy Immunotherapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Allergy Immunotherapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ALK
11.1.1 ALK Company Details
11.1.2 ALK Business Overview
11.1.3 ALK Allergy Immunotherapies Introduction
11.1.4 ALK Revenue in Allergy Immunotherapies Business (2020-2025)
11.1.5 ALK Recent Development
11.2 Stallergenes
11.2.1 Stallergenes Company Details
11.2.2 Stallergenes Business Overview
11.2.3 Stallergenes Allergy Immunotherapies Introduction
11.2.4 Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025)
11.2.5 Stallergenes Recent Development
11.3 HAL
11.3.1 HAL Company Details
11.3.2 HAL Business Overview
11.3.3 HAL Allergy Immunotherapies Introduction
11.3.4 HAL Revenue in Allergy Immunotherapies Business (2020-2025)
11.3.5 HAL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Allergy Immunotherapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergy Immunotherapies Market Perspective (2020-2031)
2.2 Global Allergy Immunotherapies Growth Trends by Region
2.2.1 Global Allergy Immunotherapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Allergy Immunotherapies Historic Market Size by Region (2020-2025)
2.2.3 Allergy Immunotherapies Forecasted Market Size by Region (2026-2031)
2.3 Allergy Immunotherapies Market Dynamics
2.3.1 Allergy Immunotherapies Industry Trends
2.3.2 Allergy Immunotherapies Market Drivers
2.3.3 Allergy Immunotherapies Market Challenges
2.3.4 Allergy Immunotherapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergy Immunotherapies Players by Revenue
3.1.1 Global Top Allergy Immunotherapies Players by Revenue (2020-2025)
3.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2020-2025)
3.2 Global Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Allergy Immunotherapies Revenue
3.4 Global Allergy Immunotherapies Market Concentration Ratio
3.4.1 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergy Immunotherapies Revenue in 2024
3.5 Global Key Players of Allergy Immunotherapies Head office and Area Served
3.6 Global Key Players of Allergy Immunotherapies, Product and Application
3.7 Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergy Immunotherapies Breakdown Data by Type
4.1 Global Allergy Immunotherapies Historic Market Size by Type (2020-2025)
4.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031)
5 Allergy Immunotherapies Breakdown Data by Application
5.1 Global Allergy Immunotherapies Historic Market Size by Application (2020-2025)
5.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Allergy Immunotherapies Market Size (2020-2031)
6.2 North America Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Allergy Immunotherapies Market Size by Country (2020-2025)
6.4 North America Allergy Immunotherapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergy Immunotherapies Market Size (2020-2031)
7.2 Europe Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Allergy Immunotherapies Market Size by Country (2020-2025)
7.4 Europe Allergy Immunotherapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergy Immunotherapies Market Size (2020-2031)
8.2 Asia-Pacific Allergy Immunotherapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Allergy Immunotherapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Allergy Immunotherapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergy Immunotherapies Market Size (2020-2031)
9.2 Latin America Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Allergy Immunotherapies Market Size by Country (2020-2025)
9.4 Latin America Allergy Immunotherapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergy Immunotherapies Market Size (2020-2031)
10.2 Middle East & Africa Allergy Immunotherapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Allergy Immunotherapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Allergy Immunotherapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ALK
11.1.1 ALK Company Details
11.1.2 ALK Business Overview
11.1.3 ALK Allergy Immunotherapies Introduction
11.1.4 ALK Revenue in Allergy Immunotherapies Business (2020-2025)
11.1.5 ALK Recent Development
11.2 Stallergenes
11.2.1 Stallergenes Company Details
11.2.2 Stallergenes Business Overview
11.2.3 Stallergenes Allergy Immunotherapies Introduction
11.2.4 Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025)
11.2.5 Stallergenes Recent Development
11.3 HAL
11.3.1 HAL Company Details
11.3.2 HAL Business Overview
11.3.3 HAL Allergy Immunotherapies Introduction
11.3.4 HAL Revenue in Allergy Immunotherapies Business (2020-2025)
11.3.5 HAL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Subcutaneous Immunotherapy
Table 3. Key Players of Sublingual Immunotherapy
Table 4. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Allergy Immunotherapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Allergy Immunotherapies Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Allergy Immunotherapies Market Share by Region (2020-2025)
Table 8. Global Allergy Immunotherapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Allergy Immunotherapies Market Share by Region (2026-2031)
Table 10. Allergy Immunotherapies Market Trends
Table 11. Allergy Immunotherapies Market Drivers
Table 12. Allergy Immunotherapies Market Challenges
Table 13. Allergy Immunotherapies Market Restraints
Table 14. Global Allergy Immunotherapies Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Allergy Immunotherapies Market Share by Players (2020-2025)
Table 16. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Table 17. Ranking of Global Top Allergy Immunotherapies Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Allergy Immunotherapies Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Allergy Immunotherapies, Headquarters and Area Served
Table 20. Global Key Players of Allergy Immunotherapies, Product and Application
Table 21. Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Table 25. Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Allergy Immunotherapies Revenue Market Share by Type (2026-2031)
Table 27. Global Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Table 29. Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Allergy Immunotherapies Revenue Market Share by Application (2026-2031)
Table 31. North America Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Allergy Immunotherapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Allergy Immunotherapies Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Allergy Immunotherapies Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 46. ALK Company Details
Table 47. ALK Business Overview
Table 48. ALK Allergy Immunotherapies Product
Table 49. ALK Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 50. ALK Recent Development
Table 51. Stallergenes Company Details
Table 52. Stallergenes Business Overview
Table 53. Stallergenes Allergy Immunotherapies Product
Table 54. Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 55. Stallergenes Recent Development
Table 56. HAL Company Details
Table 57. HAL Business Overview
Table 58. HAL Allergy Immunotherapies Product
Table 59. HAL Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 60. HAL Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Allergy Immunotherapies Picture
Figure 2. Global Allergy Immunotherapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Allergy Immunotherapies Market Share by Type: 2024 VS 2031
Figure 4. Subcutaneous Immunotherapy Features
Figure 5. Sublingual Immunotherapy Features
Figure 6. Global Allergy Immunotherapies Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Allergy Immunotherapies Market Share by Application: 2024 VS 2031
Figure 8. Allergic Rhinitis Case Studies
Figure 9. Allergic Asthma Case Studies
Figure 10. Other Case Studies
Figure 11. Allergy Immunotherapies Report Years Considered
Figure 12. Global Allergy Immunotherapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Allergy Immunotherapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Allergy Immunotherapies Market Share by Region: 2024 VS 2031
Figure 15. Global Allergy Immunotherapies Market Share by Players in 2024
Figure 16. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Allergy Immunotherapies Revenue in 2024
Figure 18. North America Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 20. United States Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 24. Germany Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Allergy Immunotherapies Market Share by Region (2020-2031)
Figure 32. China Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 40. Mexico Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 44. Turkey Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ALK Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 48. Stallergenes Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 49. HAL Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Subcutaneous Immunotherapy
Table 3. Key Players of Sublingual Immunotherapy
Table 4. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Allergy Immunotherapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Allergy Immunotherapies Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Allergy Immunotherapies Market Share by Region (2020-2025)
Table 8. Global Allergy Immunotherapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Allergy Immunotherapies Market Share by Region (2026-2031)
Table 10. Allergy Immunotherapies Market Trends
Table 11. Allergy Immunotherapies Market Drivers
Table 12. Allergy Immunotherapies Market Challenges
Table 13. Allergy Immunotherapies Market Restraints
Table 14. Global Allergy Immunotherapies Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Allergy Immunotherapies Market Share by Players (2020-2025)
Table 16. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Table 17. Ranking of Global Top Allergy Immunotherapies Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Allergy Immunotherapies Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Allergy Immunotherapies, Headquarters and Area Served
Table 20. Global Key Players of Allergy Immunotherapies, Product and Application
Table 21. Global Key Players of Allergy Immunotherapies, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Allergy Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Table 25. Global Allergy Immunotherapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Allergy Immunotherapies Revenue Market Share by Type (2026-2031)
Table 27. Global Allergy Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Table 29. Global Allergy Immunotherapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Allergy Immunotherapies Revenue Market Share by Application (2026-2031)
Table 31. North America Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Allergy Immunotherapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Allergy Immunotherapies Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Allergy Immunotherapies Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Allergy Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Allergy Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Allergy Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 46. ALK Company Details
Table 47. ALK Business Overview
Table 48. ALK Allergy Immunotherapies Product
Table 49. ALK Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 50. ALK Recent Development
Table 51. Stallergenes Company Details
Table 52. Stallergenes Business Overview
Table 53. Stallergenes Allergy Immunotherapies Product
Table 54. Stallergenes Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 55. Stallergenes Recent Development
Table 56. HAL Company Details
Table 57. HAL Business Overview
Table 58. HAL Allergy Immunotherapies Product
Table 59. HAL Revenue in Allergy Immunotherapies Business (2020-2025) & (US$ Million)
Table 60. HAL Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Allergy Immunotherapies Picture
Figure 2. Global Allergy Immunotherapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Allergy Immunotherapies Market Share by Type: 2024 VS 2031
Figure 4. Subcutaneous Immunotherapy Features
Figure 5. Sublingual Immunotherapy Features
Figure 6. Global Allergy Immunotherapies Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Allergy Immunotherapies Market Share by Application: 2024 VS 2031
Figure 8. Allergic Rhinitis Case Studies
Figure 9. Allergic Asthma Case Studies
Figure 10. Other Case Studies
Figure 11. Allergy Immunotherapies Report Years Considered
Figure 12. Global Allergy Immunotherapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Allergy Immunotherapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Allergy Immunotherapies Market Share by Region: 2024 VS 2031
Figure 15. Global Allergy Immunotherapies Market Share by Players in 2024
Figure 16. Global Top Allergy Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Allergy Immunotherapies Revenue in 2024
Figure 18. North America Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 20. United States Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 24. Germany Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Allergy Immunotherapies Market Share by Region (2020-2031)
Figure 32. China Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 40. Mexico Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Allergy Immunotherapies Market Share by Country (2020-2031)
Figure 44. Turkey Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Allergy Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ALK Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 48. Stallergenes Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 49. HAL Revenue Growth Rate in Allergy Immunotherapies Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232